https://www.the74million.org/article/lausd-posts-big-gains-in-reading-and-math-surpassing-state-and-pre-pandemic-levels/
LAUSD Posts Big Gains in Reading and Math, Surpassing State and Pre-Pandemic Levels – The 74
Stubborn achievement between racial groups gaps persist.
lausdpostsbiggainsreading
https://edsource.org/2025/california-students-struggle-math-english/742613
Despite test score gains, California students still lag behind pre-pandemic levels | EdSource
California test scores show students still face learning loss five years after the pandemic, despite recent improvements in math and English language arts.
still lag behindtest scorepre
https://madraspioneer.com/2025/10/03/oregon-students-make-small-gains-but-still-lag-pre-pandemic-proficiency-in-key-subjects/
Oregon students make small gains but still lag pre-pandemic proficiency in key subjects | Madras...
Oct 3, 2025 - Results from the latest statewide assessment tests show student proficiency in reading, writing and math are growing slightly, but are still far below...
oregon studentsmake smalllag
https://stocktwits.com/news-articles/markets/equity/why-nvda-stock-rising-china-approves-h200-chips/cmygGp7R4iv
NVDA Stock Gains Pre-Market: China Reportedly Clears H200 Chip Orders For Big Tech With Conditions
Jan 28, 2026 - According to a Reuters report, the Chinese government approved applications from tech companies to collectively acquire more than 400,000 of Nvidia’s H200 AI...
nvda stockgains premarketchip
https://www.biopharmadive.com/news/keytruda-fda-approval-perioperative-adjuvant-neoadjuvant-lung-cancer/696790/
Keytruda gains first approval for pre- and post-surgery use in lung cancer | BioPharma Dive
The Merck drug leads competitors Opdivo and Imfinzi into a new immunotherapy setting, which aims to improve outcomes following the surgical removal of tumors.
post surgerykeytrudagainspre
https://stocktwits.com/news-articles/markets/equity/ibrx-stock-gains-pre-market-after-phase-2-gioblastoma-trial-update/cmy7oypR4W6
IBRX Stock Gains Pre-Market After A Volatile Trading Session Following Phase 2 Glioblastoma Trial...
Jan 26, 2026 - Patrick Soon Shiong, ImmunityBio’s founder, took to X on Saturday to clarify what the update signified.
stock gainspre marketibrx